Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRA1: Myramistin for Acute Pharyngitis
NCT04470089Phase 2Terminated
- Sponsor
- Megapharm
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of miramistin in acute pharyngitis, sponsored by Megapharm. Started Feb 2020; status: terminated.
02
Drugs
miramistin
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT04470089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470089.